Preventing Lymphedema in Axillary Lymph Node Dissection

Overview

About this study

The researchers are trying to answer if axillary reverse mapping (ARM) with lympho-venous bypass (LVB) in patients undergoing an axillary lymph node dissection reduces the rate and severity of post-operative lymphedema of the arm.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

Patients scheduled to undergo an axillary lymph node dissection
Patients who in the surgeon's judgement are at high risk to convert to an axillary lymph node dissection based intraoperative findings
English speaking

Exclusion Criteria

Prior ipsilateral axillary lymph node dissection
Prior ipsilateral axillary radiation
Patients undergoing sentinel lymph node biopsy only or at low risk of converting to an axillary lymph node dissection in the surgeon's judgement
Previous treatment for lymphedema of either arm or prescribed prophylactic treatment for lymphedema.
Pregnant patients cannot participate in the substudy

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Jacksonville, Fla. Mayo Clinic principal investigator James Jakub, M.D.	Closed for enrollment	Contact information: Sheri Ramaker R.N. (507) 538-6984 ramaker.sheri@mayo.edu
Rochester, Minn. Mayo Clinic principal investigator James Jakub, M.D.	Closed for enrollment	Contact information: Sheri Ramaker R.N. (507) 538-6984 ramaker.sheri@mayo.edu

Mayo Clinic Location

Status

Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

James Jakub, M.D.

Closed for enrollment

Contact information:

Sheri Ramaker R.N.

(507) 538-6984

ramaker.sheri@mayo.edu

Rochester, Minn.

Mayo Clinic principal investigator

James Jakub, M.D.

Closed for enrollment

Contact information:

Sheri Ramaker R.N.

(507) 538-6984

ramaker.sheri@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials